Photo: MD Anderson cancer center/Twitter
Jun 1, 2023, 02:37
Luspatercept: A Transformative Therapy for Transfusion-Dependent Myelodysplastic Syndromes
Luspatercept is a transformative therapy for patients with transfusion-dependent myelodysplastic syndromes (MDS). Esteemed oncologist, Dr. Guillermo Garcia-Manero, believes it has the potential to become the new standard of care for MDS patients. Luspatercept works by enhancing red blood cell formation, reducing the need for frequent blood transfusions. Its introduction offers renewed hope and the potential to improve outcomes and quality of life for individuals with MDS.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46